keyword
https://read.qxmd.com/read/38196069/yes-nitrous-oxide-addiction-undeniably-exists
#1
JOURNAL ARTICLE
Caroline Victorri-Vigneau, Marie Grall Bronnec
No abstract text is available yet for this article.
January 9, 2024: Addiction
https://read.qxmd.com/read/37469693/erratum-nitrous-oxide-a-unique-official-french-addictovigilance-national-survey
#2
(no author information available yet)
[This corrects the article DOI: 10.3389/fpubh.2023.1167746.].
2023: Frontiers in Public Health
https://read.qxmd.com/read/37429062/ccl2-mcp-1-interleukin-8-and-fractalkine-cxc3cl1-potential-biomarkers-of-epileptogenesis-and-pharmacoresistance-in-childhood-epilepsy
#3
JOURNAL ARTICLE
Katarína Česká, Jan Papež, Hana Ošlejšková, Ondřej Slabý, Lenka Radová, Tomáš Loja, Zuzana Libá, Anna Svěráková, Milan Brázdil, Štefánia Aulická
OBJECTIVE: The pathophysiological processes leading to epileptogenesis and pharmacoresistance in epilepsy have been the subject of extensive preclinical and clinical research. The main impact on clinical practice is the development of new targeted therapies for epilepsy. We studied the importance of neuroinflammation in the development of epileptogenesis and pharmacoresistance in childhood epilepsy patients. METHODS: A cross-sectional study conducted at two epilepsy centers in the Czech Republic compared 22 pharmacoresistant patients and 4 pharmacodependent patients to 9 controls...
June 15, 2023: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/37206871/nitrous-oxide-a-unique-official-french-addictovigilance-national-survey
#4
JOURNAL ARTICLE
Marylène Guerlais, Aurélie Aquizerate, Arthur Lionnet, Amélie Daveluy, Mélanie Duval, Marie Gérardin, Marion Istvan, Edouard-Jules Laforgue, Caroline Victorri-Vigneau
INTRODUCTION: Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the use of psychoactive substances coordinated by the French National Agency for the Safety of Medicines and Health Products.We present the French national survey of nitrous oxide. MATERIALS AND METHODS: We analyzed all the cases with nitrous oxide from 2012 to 2021: number of notifications, characteristics of the subjects and consumption, consequences reported and their evolutions over time...
2023: Frontiers in Public Health
https://read.qxmd.com/read/37109567/influence-of-cyp2b6-genotype-on-methadone-dosage-in-patients-from-the-methadone-maintenance-treatment-mmt-program-in-pereira-colombia
#5
JOURNAL ARTICLE
Carlos Isaza, Oscar Mauricio Castaño-Ramírez, Juan Pablo Vélez, Julieta Henao, Leonardo Beltrán-Angarita, Juan Carlos Sepúlveda-Arias
Methadone treatment reduces the use of heroin and withdrawal symptoms; however, methadone is an expensive medication with a narrow safety margin. We compared the retention rates, persistence of heroin use, and quality of life of a group of patients undergoing conventional Methadone Maintenance Treatment (MMT) with a group for whom the CYP2B6 516G>T polymorphism was used in addition to the MMT to calculate the required methadone dose. Over 12 weeks, the retention rate, heroin usage, and quality of life of patients under conventional treatment (n = 34) were compared with those of patients for whom we used genetic markers to calculate methadone dosage (n = 38)...
April 18, 2023: Life
https://read.qxmd.com/read/36924882/pregabalin-does-not-reduce-postoperative-pain-after-outpatient-acl-surgery-a-case-control-study
#6
JOURNAL ARTICLE
Alexandra M Stein, Pierre-Alban Bouché, Olivier Grimaud, Paul Vedrenne, Alexandre Hardy
INTRODUCTION: In France, prescribing pregabalin requires a secure prescription valid for 6 months since the decree of 12 February 2021, based on recommendations of the French Centre for Evaluation and Information on Pharmacodependence and Addiction vigilance (CEIP-A). This led to discontinuation of this treatment as a postoperative analgesic in the French ACL Study (FAST) cohort. We aimed to evaluate the impact of this change on early postoperative pain. HYPOTHESIS: Pregabalin is an important analgesic for reducing early postoperative pain after anterior cruciate ligament (ACL) repair...
March 14, 2023: Orthopaedics & Traumatology, Surgery & Research: OTSR
https://read.qxmd.com/read/34831853/regulatory-framework-implementation-for-the-prescription-of-zolpidem-in-france-what-impact-in-the-older-people
#7
JOURNAL ARTICLE
Alexandra Jobert, Marion Istvan, Edouard-Jules Laforgue, Benoit Schreck, Caroline Victorri-Vigneau
BACKGROUND: Zolpidem is one of the most prescribed hypnotic drugs. In 2001, the World Health Organization alerted a risk of pharmacodependence associated with zolpidem. The French health authority decided in 2017 to enforce security on the prescription of zolpidem to reduce those risks. The aim of our study was to evaluate the impact of regulatory framework implementation, secure prescription pad, on the prevalence and incidence of prescriptions of zolpidem according to the age. METHODS: This study was based on an observational study using the French healthcare data system...
November 18, 2021: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/33799276/generation-of-an-ipsc-line-uninai001-a-from-a-girl-with-neonatal-onset-epilepsy-and-non-syndromic-intellectual-disability-carrying-the-homozygous-kcnq3-p-phe534ilefs-15-variant-and-of-an-ipsc-line-uninai002-a-from-a-non-carrier-unaffected-brother
#8
JOURNAL ARTICLE
Elena Longobardi, Francesco Miceli, Agnese Secondo, Rita Cicatiello, Antonella Izzo, Nadia Tinto, Sebastien Moutton, Frédéric Tran Mau-Them, Antonio Vitobello, Maurizio Taglialatela
Heterozygous variants in the KCNQ3 gene cause epileptic and/or developmental disorders of varying severity. Here we describe the generation of induced pluripotent stem cells (iPSCs) from a 9-year-old girl with pharmacodependent neonatal-onset epilepsy and intellectual disability who carry a homozygous single-base duplication in exon 12 of KCNQ3 (NM_004519.3: KCNQ3 c.1599dup; KCNQ3 p.PHE534ILEfs*15), and from a non-carrier brother of the proband. For iPSC generation, non-integrating episomal plasmid vectors were used to transfect fibroblasts isolated from skin biopsies...
March 24, 2021: Stem Cell Research
https://read.qxmd.com/read/33735176/descriptive-analysis-of-sickle-cell-patients-living-in-france-the-phedre-cross-sectional-study
#9
JOURNAL ARTICLE
Marie Gerardin, Morgane Rousselet, Marie-Laure Couec, Agathe Masseau, Marylène Guerlais, Nicolas Authier, Sylvie Deheul, Anne Roussin, Joelle Micallef, Samira Djezzar, Fanny Feuillet, Pascale Jolliet, Caroline Victorri-Vigneau
BACKGROUND: Sickle cell disease (SCD) induces chronic haemolytic anaemia and intermittent vaso-occlusion that results in tissue ischaemia causing acute, severe pain episodes that can lead to frequent hospitalizations. These consequences can have repercussions on family, social, school and/or professional life. Here, we present some of the results of the PHEDRE study (Pharmacodépendance Et DREpanocytose-drug dependence and sickle-cell disease), which is the largest study of patients with SCD in France...
2021: PloS One
https://read.qxmd.com/read/33622661/seeg-re-exploration-in-a-patient-with-complex-frontal-epilepsy-with-rapid-perisylvian-propagation-and-mixed-startle-reflex-seizures
#10
JOURNAL ARTICLE
Mihai Dragos Maliia, Philippe Kahane, Anca Nica, Ioana Mindruta, Laura Castana, Francesco Cardinale, Stefano Francione
The SEEG International Course, organised in 2017, focused on the investigation and surgery of insulo-perisylvian epilepsies. We present one representative complex case that was discussed. The patient had seizures displaying startle/reflex components. He was MRI negative, while other non-invasive investigations offered only partially concordant data. Initial SEEG exploration resulted in an incomplete definition of the epileptogenic zone. A second SEEG followed, which led to a thorough assessment of the seizure onset zone and the epileptic network, localised to the lateral inferior premotor cortex, explaining the incongruent data obtained beforehand...
February 1, 2021: Epileptic Disorders: International Epilepsy Journal with Videotape
https://read.qxmd.com/read/31937467/-community-pharmacists-students-in-pharmacy-and-requests-of-codeine-based-medicines-observational-study
#11
JOURNAL ARTICLE
Marie Baumevieille, Agathe Rambaud, Joëlle Perri-Plande, Amélie Daveluy
INTRODUCTION: The case of purple drank motivated a study to investigate the way community pharmacists and students in pharmacy managed, with patients, the abuse risk of non-prescription codeine-based medicines. METHODS: This prospective descriptive study was conducted, between September and October 2016, within a 170 community pharmacies network of Aquitaine and 437 pharmacy students of Bordeaux university (fourth, fifth and sixth year students, without selection of the pharmacies where they were able to work)...
December 20, 2019: Thérapie
https://read.qxmd.com/read/31440727/a-novel-homozygous-kcnq3-loss-of-function-variant-causes-non-syndromic-intellectual-disability-and-neonatal-onset-pharmacodependent-epilepsy
#12
JOURNAL ARTICLE
Anna Lauritano, Sebastien Moutton, Elena Longobardi, Frédéric Tran Mau-Them, Giusy Laudati, Piera Nappi, Maria Virginia Soldovieri, Paolo Ambrosino, Mauro Cataldi, Thibaud Jouan, Daphné Lehalle, Hélène Maurey, Christophe Philippe, Francesco Miceli, Antonio Vitobello, Maurizio Taglialatela
Objective: Heterozygous variants in KCNQ2 or, more rarely, KCNQ3 genes are responsible for early-onset developmental/epileptic disorders characterized by heterogeneous clinical presentation and course, genetic transmission, and prognosis. While familial forms mostly include benign epilepsies with seizures starting in the neonatal or early-infantile period, de novo variants in KCNQ2 or KCNQ3 have been described in sporadic cases of early-onset encephalopathy (EOEE) with pharmacoresistant seizures, various age-related pathological EEG patterns, and moderate/severe developmental impairment...
September 2019: Epilepsia Open
https://read.qxmd.com/read/30193805/-from-psychoactive-medicines-to-addictovigilance-in-french-public-health-code-1990-2017
#13
JOURNAL ARTICLE
Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, Amélie Daveluy, Françoise Haramburu
Addictovigilance in the French Public Health Code, in the section related to poisonous substances, refers to a monitoring system developed since 1990: control of psychoactive substances and products, with medicinal use or not, was completed by a specific system focused on evaluation and information on pharmacodependance in 1999. The French medicines agency (Agence du médicament) created in 1993 was involved in this monitoring system; pharmacodependance evaluation was added by law to the missions of the agencies that followed: the Agence française de sécurité sanitaire des produits de santé missions (AFSSAPS, 1998) and the Agence nationale de sécurité du médicament et des produits de santé (ANSM, 2011)...
August 3, 2018: Thérapie
https://read.qxmd.com/read/27302554/multicentre-study-for-validation-of-the-french-addictovigilance-network-reports-assessment-tool
#14
MULTICENTER STUDY
Caroline Victorri-Vigneau, Jean Benoit Hardouin, Morgane Rousselet, Marie Gerardin, Marylène Guerlais, Morgane Guillou, Marie Bronnec, Véronique Sébille, Pascale Jolliet
AIMS: The French health authority (ANSM) is responsible for monitoring medicinal and other drug dependencies. To support these activities, the ANSM manages a network of 13 drug dependence evaluation and information centres (Centres d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance - CEIP-A) throughout France. In 2006, the Nantes CEIP-A created a new tool called the EGAP (Echelle de GrAvité de la Pharmacodépendance- drug dependence severity scale) based on DSM IV criteria...
October 2016: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/27293246/topical-steroid-damaged-dependent-face-tsdf-an-entity-of-cutaneous-pharmacodependence
#15
JOURNAL ARTICLE
Koushik Lahiri, Arijit Coondoo
Topical Steroid Damaged/Dependent face (TSDF) is a phenomenon which has been described very recently (2008). It is characterized by a plethora of symptoms caused by an usually unsupervised misuse/abuse/overuse of topical corticosteroid of any potency on the face over an unspecified and/or prolonged period of time. This misuse and damage have a serious effect on the quality of life of the patients in general and the skin of the face in particular. Management is difficult and necessitates psychological counseling as well as physical soothing of the sensitive skin...
2016: Indian Journal of Dermatology
https://read.qxmd.com/read/27235654/-characteristics-of-subjects-under-opiate-maintenance-treatment-in-primary-care-using-the-opema-data-2013
#16
JOURNAL ARTICLE
Gaëtan Gentile, Elisabeth Frauger, Adeline Giocanti, Vanessa Pauly, Véronica Orleans, Despina Amaslidou, Xavier Thirion, Joëlle Micallef
AIM: The objective of the study is to describe the characteristics of subjects under opiate maintenance treatment by general practionners (GPs). METHOD: Data analysis from observatory for pharmacodependency in ambulatory medicine survey (observation des pharmacodépendances en médecine ambulatoire [OPEMA]) program in 2013 of the subjects under high dosage buprenorphine (HDB) and methadone prescribed or obtained illegally reported by GPs in France. RESULTS: Survey concerned consumers with 862, 433 and 429 of high dosage buprenorphine and respectively methadone...
June 2016: Thérapie
https://read.qxmd.com/read/25858577/evaluation-of-abuse-and-dependence-in-addiction-monitoring-systems-tramadol-as-an-example
#17
JOURNAL ARTICLE
Anne Roussin, Odile Doazan-d'Ouince, Hélène Géniaux, Clémence Halberer
The objective of this paper is to present an evaluation of the potential for abuse of and dependence on a drug from the data obtained from the different pharmacoepidemiological tools used by the French network for evaluation and information on pharmacodependence and addiction monitoring taking the example of tramadol. Comparison of the data from spontaneous reports with surveys in specific populations and with evaluations of indicators of diverted uses does not highlight a major problem of tramadol abuse and dependence in terms of public health, but stresses the importance of paying attention to the signal...
March 2015: Thérapie
https://read.qxmd.com/read/24467433/an-update-on-zolpidem-abuse-and-dependence
#18
REVIEW
Caroline Victorri-Vigneau, Marie Gérardin, Morgane Rousselet, Marylène Guerlais, Marie Grall-Bronnec, Pascale Jolliet
In 2004, the health authorities (French National Agency for Medicines and Health Products Safety-ANSM) modified the summary of zolpidem characteristics. Particularly it now includes the sentence "a pharmacodependence may materialize." The current article aims to show that despite this modification, zolpidem continues to be associated with problematic drug use, as the official system (Center for Evaluation and Information on Pharmacodependence-Addictovigilance network) providing information on the abuse and dependence potential of drugs informs us...
2014: Journal of Addictive Diseases
https://read.qxmd.com/read/23877252/pharmacoepidemiological-characterisation-of-zolpidem-and-zopiclone-usage
#19
JOURNAL ARTICLE
Caroline Victorri-Vigneau, F Feuillet, L Wainstein, M Grall-Bronnec, J Pivette, A Chaslerie, V Sébille, P Jolliet
PURPOSE: Zolpidem and zopiclone are two widely used non-benzodiazepine hypnotics whose usage seems to be associated to pharmacodependence. However, to our knowledge, there has as yet been no published epidemiological study which has compared their abuse or dependence potential. We used a pharmacoepidemiological approach to identify and characterise zolpidem and zopiclone users in real life situations. METHODS: Regular users of zolpidem or zopiclone were identified in the database of a French regional health insurance organisation...
November 2013: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/23110841/-general-practitioners-contribution-to-dependence-assessment-the-opema-programme
#20
JOURNAL ARTICLE
Christophe Moracchini, Veronica Orleans, Samira Miloudi, Elisabeth Frauger, Joëlle Micallef, Xavier Thirion
Aim. This study presents the OPEMA (Observation des pharmacodépendances en médecine ambulatoire) programme and the main results of its last annual survey (november 2010). Method. Collected data concern mainly subjects' sociodemographic situation, their state of health and their current consumption of psychoactive substance. Results. In 2010, 1394 subjects have been included, describing 2 450 consumptions of psychoactive susbtance. Their mean age is 38,2±12,7 years. Eighty-six per cent have a stable accomodation and 52% are in employment...
July 2012: Thérapie
keyword
keyword
77307
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.